TORONTO, Dec. 18, 2017 /CNW/ - Horizons ETFs Management (Canada) Inc. ("Horizons ETFs") announced it has completed the quarterly rebalance of the constituent holdings of the Horizons Marijuana Life Sciences Index ETF ("HMMJ") on December 15, 2017. As a result, 11 new holdings have been added to HMMJ's portfolio.
HMMJ is the world's first ETF that offers direct exposure to North American-listed securities that are involved with marijuana bioengineering and production. The HMMJ portfolio has expanded to include the following constituents:
HMMJ is an index (or passively managed) ETF, which seeks to replicate, to the extent possible, the performance of the North American Marijuana Index (the "Index"), net of expenses. The Index is designed to provide exposure to the performance of a basket of North American publicly listed life sciences companies with significant business activities in the marijuana industry. The Index selects from a current universe of companies that have operations that may include one or more of biopharmaceuticals, medical manufacturing, distribution, bio-products and other ancillary businesses related to the marijuana industry.
"Cannabis has been one of the newest and fastest-growing asset classes of 2017, presently valued at approximately $23 billion," said Steve Hawkins, President and Co-CEO of Horizons ETFs. "The continued expansion of HMMJ's Index and portfolio demonstrates how quickly this sector has evolved and why it should be considered a long-term, domestic investment opportunity for Canadian investors."
Rebalancing of the North American Marijuana Index occurs before the end of each calendar quarter. At that point, all stocks eligible for inclusion in the Index are weighted by their respective market capitalization. However, no single stock can exceed 10% of the weight of the index at the rebalance date.
In conjunction with the recently announced Index rebalance by the Index calculation agent (Solactive AG), HMMJ has also rebalanced its portfolio holdings. The holdings of the ETF and their current portfolio weights are regularly updated on our website at www.HorizonsETFs.com/HMMJ.
It is important to note that HMMJ may not hold all of the constituent names in the Index. HMMJ's manager, through the use of a stratified sampling strategy, may invest in securities that closely match the investment characteristics of the Index, and are consistent with the investment objective and strategy of the ETF.
About Horizons ETFs Management (Canada) Inc. (www.HorizonsETFs.com)
Horizons ETFs Management (Canada) Inc. is an innovative financial services company and offers one of the largest suites of exchange traded funds in Canada. The Horizons ETFs product suite includes a broadly diversified range of solutions for investors of all experience levels to meet their investment objectives in a variety of market conditions. Horizons ETFs currently has more than $8.7 billion of assets under management and 81 ETFs listed on the Toronto Stock Exchange. Horizons ETFs Management (Canada) Inc. is a member of the Mirae Asset Global Investments Group.
About Solactive (www.solactive.com)
Solactive AG is an innovative index provider that focuses on the development, calculation and distribution of tailor-made indices over all asset classes. The company was established in 2007 and is headquartered in Frankfurt, Germany. Over 350 international clients, including major investment banks, ETF providers and asset managers have embraced Solactive's mutually attractive investment ideas. As at October 2017, more than 260 ETFs are linked to Solactive's indices and over USD $100 billion is invested in products linked to indices calculated by Solactive.
Horizons ETFs is a member of Mirae Asset Global Investments. Commissions, management fees, expenses and applicable sales taxes all may be associated with an investment in the Horizons Marijuana Life Sciences Index ETF managed by Horizons ETFs Management (Canada) Inc. (the "ETF"). The ETF is not guaranteed, its value changes frequently and past performance may not be repeated. The Prospectus contains important detailed information about the ETF. Please read the Prospectus before investing.
HMMJ is not sponsored, promoted, sold or supported in any other manner by Solactive AG nor does Solactive AG offer any express or implicit guarantee or assurance either with regard to the results of using the Index and/or Index trade name or the Index Price at any time or in any other respect. The Index is calculated and published by Solactive AG. Solactive AG uses its best efforts to ensure that the Index is calculated correctly. Irrespective of its obligations towards the Issuer, Solactive AG has no obligation to point out errors in the Index to third parties including but not limited to investors and/or financial intermediaries of the financial instrument. Neither publication of the Index by Solactive AG nor the licensing of the Index or Index trade name for the purpose of use in connection with the financial instrument constitutes a recommendation by Solactive AG to invest capital in HMMJ nor does it in any way represent an assurance or opinion of Solactive AG with regard to any investment in HMMJ.